Symbol
| PNPLA6
| contributors: npt/shn - updated : 25-09-2012
|
HGNC name
| patatin-like phospholipase domain containing 6
|
HGNC id
| 16268
|
corresponding disease(s)
|
SPG39
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
| LOH
|  
|  
|
in vacuolar pathology of the nervous system | |
Susceptibility
|
to organophosphorus compound-induced delayed neuropathy |
Variant & Polymorphism
other
| mutation increasing the risk of organophosphorus compound-induced delayed neuropathy |
|
|
Candidate gene
Marker
Therapy target
| | | |
| Nte(-/-) mice die after embryonic day 8, and Nte(+/-) mice have lower activity of Nte in the brain and higher mortality when exposed to the Nte-inhibiting compound ethyl octylphosphonofluoridate | |
Heterozygous NTE(+/-) mice displayed a 50% reduction in NTE activity but underwent normal organ development while NTE(-/-) mice died at embryonic day 9 postcoitum |
|
PNPLA6 insufficiency using morpholino oligonucleotide knockdown in zebrafish results in developmental abnormalities and motor neuron defects including axon truncation and branching |